NO20064601L - Mtp-inhibiting aryl-piperidines or -piperazines substituted with 5-membered heterocycles - Google Patents

Mtp-inhibiting aryl-piperidines or -piperazines substituted with 5-membered heterocycles

Info

Publication number
NO20064601L
NO20064601L NO20064601A NO20064601A NO20064601L NO 20064601 L NO20064601 L NO 20064601L NO 20064601 A NO20064601 A NO 20064601A NO 20064601 A NO20064601 A NO 20064601A NO 20064601 L NO20064601 L NO 20064601L
Authority
NO
Norway
Prior art keywords
compounds
mtp
membered heterocycles
piperidines
diabetes
Prior art date
Application number
NO20064601A
Other languages
Norwegian (no)
Other versions
NO337711B1 (en
Inventor
Leo Jacobus Jozef Backx
Peter Walter Maria Roevens
Marcel Viellevoye
Lieven Meerpoel
Joannes Theodorus Mari Linders
Libuse Jaroskova
Louis Jozef Van Der Veken
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2005/051010 external-priority patent/WO2005085226A1/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of NO20064601L publication Critical patent/NO20064601L/en
Publication of NO337711B1 publication Critical patent/NO337711B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4192—1,2,3-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4196—1,2,4-Triazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Den foreliggende oppfinnelse vedrører nye aryl-piperidin eller -piperazinforbindelser substituert med visse 5-leddede heterocykler som har apoB-sekresjon/MTP-hemmende aktivitet og ledsagende lipidsenkende aktivitet. Oppfinnelsen vedrører videre fremgangsmåter for å fremstille slike forbindelser, farmasøytiske sammensetninger omfattende forbindelsene samt anvendelsen av forbindelsene som en medisin for behandlingen av hyperlipidemi, obesitet og type II diabetes. Oppfinnelsen vedrører videre fremgangsmåter for å fremstille slike forbindelser, farmasøytiske sammensetninger omfattende forbindelsene samt anvendelsen av forbindelsene som en medisin for behandlingen av aterosklerose, pankreatitt, obesitet, hypertriglyseridemi, hyperkolesterolemi, hyperlipidemi, diabetes og type II diabetes.The present invention relates to novel aryl-piperidine or piperazine compounds substituted with certain 5-membered heterocycles having apoB secretion / MTP inhibitory activity and concomitant lipid-lowering activity. The invention further relates to processes for the preparation of such compounds, pharmaceutical compositions comprising the compounds and the use of the compounds as a medicine for the treatment of hyperlipidemia, obesity and type II diabetes. The invention further relates to processes for the preparation of such compounds, pharmaceutical compositions comprising the compounds and the use of the compounds as a medicine for the treatment of atherosclerosis, pancreatitis, obesity, hypertriglyceridemia, hypercholesterolemia, hyperlipidemia, diabetes and type II diabetes.

NO20064601A 2004-03-10 2006-10-10 Mtp-inhibiting aryl-piperidines or -piperazines substituted with 5-membered heterocycles NO337711B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP04075771 2004-03-10
US55633604P 2004-03-25 2004-03-25
PCT/EP2005/051010 WO2005085226A1 (en) 2004-03-10 2005-03-07 Mtp inhibiting aryl piperidines or piperazines substituted with 5-membered heterocycles

Publications (2)

Publication Number Publication Date
NO20064601L true NO20064601L (en) 2006-10-10
NO337711B1 NO337711B1 (en) 2016-06-06

Family

ID=34921309

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064601A NO337711B1 (en) 2004-03-10 2006-10-10 Mtp-inhibiting aryl-piperidines or -piperazines substituted with 5-membered heterocycles

Country Status (4)

Country Link
CY (1) CY1108764T1 (en)
DE (1) DE602005011127D1 (en)
HR (1) HRP20090085T3 (en)
NO (1) NO337711B1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0013383D0 (en) * 2000-06-01 2000-07-26 Glaxo Group Ltd Therapeutic benzamide derivatives
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Polyarylcarboxamides useful as lipid lowering agents

Also Published As

Publication number Publication date
HRP20090085T3 (en) 2009-03-31
NO337711B1 (en) 2016-06-06
CY1108764T1 (en) 2014-04-09
DE602005011127D1 (en) 2009-01-02

Similar Documents

Publication Publication Date Title
EA200970398A1 (en) DERIVATIVES OF PIPERIDINE OR PIPERAZIN SUBSTITUTED TETRAHYDRO-NAPTHALINE 1-CARBONIC ACID INHIBITING MTR
EA200601660A1 (en) MTP INHIBITING ARYLIPIPERIDINES OR PIPERASINES FURNISHED WITH 5-MEMBER HETEROCYCLES
HRP20050103B1 (en) N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b secretion
NO20090321L (en) Use of substituted 2-aminotyethralines for the manufacture of a drug for the prevention, relief and / or treatment of various types of pain
MA33593B1 (en) Heterocyclic compounds and their uses
NO20064362L (en) Compounds, pharmaceutical compositions and methods for use in the treatment of metabolic diseases
NO20070606L (en) Inhibitors of IAP
NO20020811L (en) Sulfonyl carboxamide derivatives, processes for their preparation and their use as drugs
MX2010009752A (en) Oxadiazoanthracene compounds for the treatment of diabetes.
NO20084318L (en) Inhibitors of II-beta-hydroxysteroid dehydrogenase I
NO20076478L (en) Substituted oxadiazole derivatives as positive allosteric modulators of metabotropic glutamate receptors
NO20084852L (en) MGLUR5 modulators V
NO20071314L (en) Peptidic vasopressin receptor agonists
BRPI0806789B8 (en) compound or a pharmaceutically acceptable salt thereof, pharmaceutical composition, and, use of a compound or a pharmaceutically acceptable salt thereof
NO20060383L (en) Substituted diketopiperazines and their use as oxytocin antagonists
NO20060718L (en) Substituted thiophones and their use
EA201001586A1 (en) COMPOUNDS AND COMPOSITIONS AS ITPKB INHIBITORS
EA200601120A1 (en) N-arylpiperidine-substituted biphenylcarboxamides as apolipoprotein b
NO20070980L (en) Selected condensed heterocycles and applications thereof
NO20083790L (en) New therapeutic combinations for the treatment or prevention of psychotic disorders
BRPI0717314A2 (en) TETRAHYDRO-NAPHTHALENE-1-CARBOXYLIC ACID DERIVATIVES MTP INHIBITORS
NO20064601L (en) Mtp-inhibiting aryl-piperidines or -piperazines substituted with 5-membered heterocycles
NO20076037L (en) New thiazolidinones without basic nitrogen, their preparation and use as pharmaceutical agents
DE602007004348D1 (en) MEDICAMENT FOR THE TREATMENT OF SARCOGLYKANOPATHIA
NO20076038L (en) New thiazolidinones without basic nitrogen, their preparation and use as pharmaceutical agents

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees